Tolterodine Tartrate film-coated tablets

Dosage instructions for Tolterodine Tartrate necessitate strict adherence to your doctor’s guidance. It is imperative to take the medication precisely as prescribed; if uncertainties arise, consult your healthcare provider or pharmacist for clarification. Typically, the recommended dose entails one 2 mg tablet administered twice daily. However, adjustments may be made for patients with kidney or liver conditions, or those experiencing troublesome side effects, wherein the dosage might be reduced to one 1 mg tablet twice daily under your doctor’s discretion. It’s important to note that Tolterodine Tartrate is not intended for paediatric use. Administer the tablets orally, swallowing them whole. Regarding the duration of treatment, your doctor will specify the timeline tailored to your condition. Do not prematurely discontinue treatment even if immediate effects aren’t evident, as bladder adaptation requires time. Complete the prescribed course of tablets as directed by your doctor, and if efficacy isn’t observed, communicate with your healthcare provider. Re-evaluation of treatment benefits typically occurs after 2 or 3 months. Always consult your doctor before considering discontinuation of treatment.

While tolterodine is generally well-tolerated, like all medications, it can induce side effects, although not everyone experiences them. If you encounter symptoms of angioedema, such as facial, tongue, or throat swelling, difficulty swallowing, hives, or breathing difficulties, seek immediate medical attention. Additionally, hypersensitivity reactions like itching, rash, hives, or breathing issues warrant prompt medical evaluation, although they occur uncommonly. Notify your doctor promptly or visit the emergency department if you notice chest pain, breathing difficulties, unusual fatigue (even at rest), nocturnal breathing difficulties, or leg swelling, as these could indicate heart failure, albeit uncommonly. Common side effects during tolterodine treatment, occurring in more than 1 in 10 patients, encompass dry mouth and headaches. For further information please refer to the Patient Information Leaflet.

Tolterodine Tartrate should not be taken if you have known hypersensitivity to tolterodine or any of its components, as listed in section 6 of the PIL. Additionally, refrain from its use if you experience urinary retention, have uncontrolled narrow-angle glaucoma, suffer from myasthenia gravis, severe ulcerative colitis, or toxic megacolon. Prior to taking Tolterodine Tartrate, it is crucial to heed warnings and take precautions. If you encounter difficulties in passing urine or experience a weak urine stream, have gastrointestinal disorders affecting food passage or digestion, or suffer from kidney or liver problems, consult your healthcare provider for appropriate guidance and potential adjustments to treatment. For further information please refer to the Patient Information Leaflet.

It’s crucial to inform your doctor about any current or recent medication usage, including over-the-counter drugs. Tolterodine, the active component of tolterodine, may interact with various other medicinal products, necessitating caution. Specifically, avoid combining tolterodine with certain antibiotics (such as erythromycin, clarithromycin), medications for fungal infections (including ketoconazole, itraconazole), and drugs for HIV treatment. Exercise caution when using tolterodine alongside medications affecting food passage (like metoclopramide and cisapride), those for irregular heartbeat (such as amiodarone, sotalol, quinidine, procainamide), and those with similar or opposite modes of action to tolterodine (antimuscarinic or cholinergic properties, respectively). Consult your doctor if you’re uncertain about potential interactions. Tolterodine Tartrate can be taken with or without food, offering flexibility in administration .

During pregnancy, it is advised to avoid the use of tolterodine. If you are pregnant, suspect pregnancy, or are planning pregnancy, promptly inform your doctor. As for breastfeeding, the excretion of tolterodine into breast milk is not fully understood. Consequently, breastfeeding is not recommended while taking tolterodine. Before initiating any medication, including tolterodine, consult your doctor or pharmacist for guidance.

For alternatives and additional products, such as TENA Proskin Pants we encourage you to visit our UTIs / Cystitis homepage. There, you’ll find a wide range of options tailored to assist you if you’re experiencing incontinence. Our comprehensive selection aims to cater to diverse needs and preferences, ensuring you find the right solution for your specific situation. Visit our homepage today to explore the array of offerings designed to support and enhance your comfort and well-being.